Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Jun 10;17(6):e0269877. doi: 10.1371/journal.pone.0269877

Diabetes mellitus and its association with central obesity, and overweight/obesity among adults in Ethiopia. A systematic review and meta-analysis

Temesgen Muche Ewunie 1,*, Daniel Sisay 2, Robel Hussen Kabthymer 1
Editor: Paolo Magni3
PMCID: PMC9187119  PMID: 35687581

Abstract

Background

Nowadays, diabetes mellitus is a serious public health problem in Ethiopia that has a profound impact on the health care system. However, no systematic synthesis and meta-analysis has been performed to depict the national prevalence. Hence, we authors aimed to assess the pooled prevalence of diabetes mellitus and its association with central obesity, overweight/obesity among adults in Ethiopia.

Methods

We did a systematic review and meta-analysis of 15 eligible studies on the national prevalence of DM and its association with central obesity, and overweight/obesity among adults in Ethiopia. We searched PubMed/Medline, Science Direct, Embase, and Google Scholar, from August 01 up to October 28, 2021, in accordance with PRISMA guidelines. Joanna Briggs Institute (JBI) critical appraisal tool was used to assess the quality of studies. Analysis was done using STATA version 14 software. Heterogeneity was checked using the I-squared test, and the publication bias was examined by funnel plot and eggers test. Moreover, Sensitivity analysis was done to check the influence of small studies on the outcome. The trim and fill analysis was performed to estimate the potentially missing articles because of publication bias.

Result

Total of 15 studies that met the inclusion criteria were included and the pooled prevalence of diabetes mellitus of the Federal Democratic Republic of Ethiopia was 6.26 (95%CI: 4.74–7.78). In the subgroup analysis, the prevalence of diabetes mellitus among the studies conducted in 2017 and before was 4.56 (95%CI: 2.98–6.14) but in studies done after 2017 was 7.55(95%CI: 4.69–10.41). The burden of diabetes mellitus was 5.79 times higher among those adults who had central obesity (OR = 5.79; 95%CI; 3.14–10.70), 5.70 times higher among adults who had overweight/obesity (OR = 5.70, 95%CI: 3.35–9.70).

Conclusion

The national prevalence of diabetes mellitus among adults in Ethiopia was higher and associated with central obesity, and overweight/obesity. Hence, the government of Ethiopia and stakeholders should give attention to strengthen the current health system regarding non-communicable diseases like diabetes mellitus and obesity/overweight.

Introduction

Diabetes mellitus (DM) is a metabolic disease characterized by prolonged hyperglycemia due to either inadequate production of insulin by the pancreas or the cells of the body not responding properly to the produced insulin [1]. It is a major public health problem worldwide [2] and is largely associated with lifestyle changes [3].

Globally, the estimated prevalence of diabetes increases from time to time. It reached 463 million people in 2019, and this will be five hundred seventy-eight million, seven hundred million in 2030, and 2045, respectively, due to the current projection. Furthermore, the problem is worse in urban and high-income countries than in rural and low-income countries, with different consequences for the health, socioeconomic, and productivity of countries in general and people in particular [4].

The increment of diabetes mellitus prevalence is now becoming more significant in developing countries than in developed countries, where there are scarce resources for diabetic management, contributing to an increased risk of premature morbidity and mortality with major social and economic consequences [5]. The prevalence of diabetes has been steadily increasing over the past few decades. For instance, raised blood glucose is a common effect of uncontrolled diabetes and may, over time, lead to serious damage to the heart, blood vessels, eyes, kidneys, and nerves [4, 5].

Diabetes is a significant burden on the health care system and the economy at the national level in Sub–Saharan African countries, with the five leading countries with diabetes in 2017 being Ethiopia, South Africa, the Democratic Republic of the Congo, Nigeria, and Tanzania. Furthermore, the Sub–Saharan region is at high risk of receiving the highest percentage of cases of diabetes in any region in the world, so diabetes is a significant burden on the health care system and the economy at the national level [6].

The Ethiopian Diabetes Association (EDA) estimated a 2–3% prevalence in 2013 in Ethiopia. In 2015, the EDA (1.33 million) and IDF (1.30 million) reported almost the same number of people living with diabetes in the country [7].

Nowadays, the burden of diabetes mellitus has been increasing radically. The impact is high, especially in Ethiopia, where resources are limited to identifying the problem and developing need-based clinical and community intervention.

This burden can be measured through direct medical costs, indirect costs associated with productivity loss, premature mortality, and the negative impact of diabetes on nations’ gross domestic product (GDP). Therefore, a systematic review and meta-analysis is needed that shows the burden of DM at the national level and its association with central obesity, and overweight and obesity among adult in Ethiopia.

Materials and methods

Search strategy and review process

The authors (TME and DS) conducted a comprehensive search using electronic databases (PubMed/Medline, Science Direct, and Embase) and manual search (Google Scholar) from August 1 up to October 28, 2021. This review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines [8]. We authors, used the following keywords during our search; ((Prevalence) OR (burden)) OR (epidemiology)) OR (level)) AND (associated factors)) OR (determinants)) AND (diabetes mellitus)) AND (adult)) AND (Ethiopia). Then this systematic review and meta-analysis was performed in accordance with The Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist for reporting a systematic review or meta-analysis protocol (Fig 1).

Fig 1. A PRISMA flow chart for systematic review and meta-analysis.

Fig 1

Eligibility criteria

  1. Study area: Research articles conducted only in Ethiopia were included.

  2. Study design: Observational studies (cross-sectional, case-control, and cohort studies) with original data reporting the prevalence of DM and its associated factors were included.

  3. Language: Literatures published in the English language were considered.

  4. Population: Study conducted on adults population were included.

  5. Publication issue: Both published and unpublished articles were included in this review.

  6. Study period: Study with no time limit on study period were included.

  7. Studies that do not report the prevalence of diabetes mellitus were excluded.

Data extraction

A reviewer (T.M.E) extracted the data using a standard Microsoft excel sheet adapted using the Joanna Briggs Institute (JBI) quality score [9]. And the name of the first author, publication year, region, setting, quality score, sample size, prevalence, and diagnostic criteria were considered in the extraction process. The second reviewer (D.S) revised the extracted data.

Data processing and analysis

In this systematic review and meta-analysis, the data was extracted using standard Microsoft excel format and then exported into STATA version 14 software for analysis. We authors used the random-effects model were used to pool outcome results from eligible studies. The pooled prevalence of the outcome variable with 95% confidence interval was reported. Heterogeneity was checked using the I-squared test. To assess the publication bias we used funnel plot observation subjectively, Begg test, and egger’s test. Statistically, publication bias was declared at a p-value less than 0.05. Sensitivity analysis (leave-one-out) was done to test the influence of a single study on the pooled prevalence, by assuming zero differences between groups. The trim and fill analysis was performed to estimate the potentially missing articles because of publication bias. And sub-group analysis was performed by study period, region, and sample size.

Results

Fifteen studies [7, 1022], with a total of 13,774 adults, met the inclusion criteria (Fig 1), and a total of 13,774 adults aged 15 years and above were included in this review. Also, articles were identified using an electronic database and a manual search for the prevalence of diabetes mellitus among adults in Ethiopia. All the studies were observational (cross-sectional studies) and the smallest sample size was 392 in Gondar Ethiopia [18], while the largest sample size was 2922 in Bona district, SNNPR [7] participants. Studies were conducted in different parts of Ethiopia, 3 were conducted in the southern region [7, 15, 22], 6 conducted in Amhara [10, 12, 13, 17, 18, 20], 4 conducted in Addis Ababa [11, 13, 19, 21] and 2 in the Sidama region [14, 23]. The sample size of the included studies was ranging from 1.9% [7] to 14.8% [11] (Table 1).

Table 1. Summary of included studies to assess the pooled prevalence of diabetes mellitus and its association with central obesity and overweight/obesity in Ethiopia.

Author Publication Year Region Setting Quality Ass.(JBI) Sample Size Outcome Prevalence Diagnostic Criteria
Sahile and Bekele [11] 2020 AA Urban 7 758 112 14.8 Not stated
Endris et al. [12] 2019 Amhara Urban 6 587 40 6.8 ADA
Seifu et al. [23] 2020 Sidama Both 7 519 64 12.4 WHO
Dereje N, et al. [22] 2020 SNNPR Urban 6 634 36 5.7 WHO
Aynalem and Zeleke [15] 2018 SNNPR Urban 5 414 26 6.5 ADA
Alemayehu Z. et al. [7] 2018 SNNPR Both 6 2922 51 1.9 ADA
Woldesemayat et al. [13] 2019 AA Urban 7 422 10 2.6 WHO
Kassa A. and Woldesemayat E. [14] 2019 Sidama Urban 7 423 50 12.2 Not stated
Abebe et al. [20] 2014 Amhara Both 8 2200 77 3.6 WHO
Tesfaye et al. [19] 2016 AA Urban 7 1003 47 5 Not stated
Wolde et al. [10] 2020 Amhara Both 7 805 49 6.3 WHO
Uhomoibhi p. [21] 2003 AA Urban 5 533 16 3.4 WHO
Animaw W and Seyoum y. [16] 2017 Amhara Both 6 1405 46 3.3 Not stated
Wondemagegn et al. [17] 2017 Amhara Both 7 757 83 11 WHO
Worede et al. [18] 2017 Amhara Urban 7 392 9 2.3 ADA

Notice: AA; Addis Ababa, ADA; American Diabetic Association, WHO; World Health Organization

Meta-analysis of diabetes mellitus among adults

The pooled prevalence of diabetes mellitus in Ethiopia was found to be 6.26% (95%CI: 4.74–7.78). The heterogeneity of the pooled estimate (I2 = 94.6%, P = 0.000) and a random-effects model was used to decrease heterogeneity (Fig 2).

Fig 2. Forest plot of fifteen studies which included to assess the pooled prevalence of diabetes mellitus in Ethiopia.

Fig 2

Publication bias

Publication bias was checked using a funnel plot and objectively by the eggers test. We found in this study publication bias, as evidenced by substantial asymmetric funnel plot (Fig 3) and statistically significant begg test (P = 0.001) (S1 Fig) and egger’s test (P = 0.000) (S2 Fig). In addition to this, the sensitivity analysis finding revealed that the studies had no effect on the pooled prevalence of diabetes mellitus among adults in Ethiopia (Fig 4).

Fig 3. Funnel plot test output of the included studies.

Fig 3

Fig 4. Output of sensitivity analysis of 15 studies.

Fig 4

Subgroup analysis

In the subgroup analysis, the pooled prevalence of diabetes mellitus was 4.56% from the studies conducted in 2017 and before. Whereas, the prevalence of DM was 7.55 in the studies carried out after 2017 (Table 2).

Table 2. Subgroup analysis of diabetes mellitus by publication year and sample size of studies conducted in Ethiopia.

Category Number of studies ES(95%CI) I-Squared (%)
Region Addis Ababa 4 6.33(2.21–10.46) 95.7
Amhara 6 5.35(3.46–7.22) 91.4
Sidama 2 12.31(10.20–14.43) 0.0
SNNPR 3 4.56(1.26–7.84) 92.7
Publication year 2017 and before 6 4.56(2.98–6.14) 89.2
After 2017 9 7.55(4.69–10.41) 96.2
Sample size ≥700 7 6.29(4.11–8.46) 96.5
<700 8 6.27(3.97–8.57) 90.8

Association of diabetes mellitus with overweight/obesity

In this review, participants with overweight/obesity reported from nine studies [7, 1115, 19, 22, 23] and the odds of diabetes mellitus was 5.70 times higher among adults who had overweight/obesity than their counterparts (OR = 5.70, 95%CI: 3.35–9.70) (Fig 5).

Fig 5. Forest plot showing the association between DM and overweight/obesity in Ethiopia.

Fig 5

Association of diabetes mellitus with central obesity

The association between diabetes mellitus and central obesity was computed from six studies [7, 12, 13, 15, 19, 23]. The prevalence of diabetes mellitus was 5.79 times higher among those adults who had central obesity than those who did not have central obesity (OR = 5.79; 95%CI; 3.14–10.70) (Fig 6).

Fig 6. Forest plot showing the association between DM and central obesity in Ethiopia.

Fig 6

Discussion

In this systematic review and meta-analysis and a total of 13,774 study participants were included from fifteen eligible studies [7, 1023]. The pooled prevalence of diabetes mellitus among adults in Ethiopia was found to be 6.26%. This is higher than the study conducted in Nigeria, 3% [24]. But lower than the studies conducted in developed countries, like Germany, 14% [25], Thailand 16.8% [26], and Belgium 9.4% [27]. This could be due to different reasons such as sedentary lifestyles and urbanization in developed countries. And consistent with the study conducted in New Zealand 6% [28].

The current review showed that there is an increment in the prevalence of DM from time to time. The present finding is supported by different the studies [29, 30]. This might be an increment of unhealthy dietary behaviour like high fat diet consumption, physical inactivity, and urbanization, which are the risk factors for non-communicable diseases including diabetes mellitus.

In addition, we observed that diabetes mellitus was positively associated with increased odds of having obesity/overweight and central obesity. This finding is consistent with the study conducted in China [31]. In this review, a high degree of heterogeneity was observed. This might be due to differences in the categorization of overweight/obesity. Although the pathophysiology of the relationship between diabetes mellitus and central obesity, overweight/obesity is still not well known, having central obesity and/or being overweight make the treatment/control of diabetes mellitus difficult among DM patients.

This meta-analysis has several strengths. To our knowledge, it is the first review that combined fifteen primary studies and provide up-to-date data that showed the national burden of diabetes in Ethiopia. In spite of these strengths, the review has some limitations, such as included studies were cross-sectional, which could not show the causal association between diabetes mellitus with abdominal obesity and overweight/obesity. Despite the estimated burden of diabetes mellitus and its association with obesity, we are unable to assess the pathophysiology between DM and obesity. Because of inadequate primary studies, the review was conducted based on the studies conducted in four regions of the country from a total of ten regions which limits the generalizability of the findings at the national level. Furthermore, although different efforts have been made during analysis to reduce the effect of bias, the presence of publication bias is also the other limitation of this meta-analysis. Therefore, a follow-up study should be conducted in order to confirm the association between the outcome variable and abdominal obesity, overweight/obesity in the future.

Conclusion

The current review found evidence that the prevalence of diabetes mellitus among adults was dramatically increasing from time to time. It has a strong association with central obesity, and overweight/obesity. To mitigate this health challenge, it is necessary to integrate control strategies with other health services, promote nutritional intervention, and encourage physical activity.

Supporting information

S1 Table. PRISMA 2020 checklist.

(DOCX)

S2 Table. Literature screening Microsoft excel sheet.

(DOCX)

S3 Table. JBI-quality assessment tool for cross-sectional studies.

(DOCX)

S1 Fig. Begg’s test analysis for diabetes mellitus and its association with central obesity, and overweight/obesity among adults.

(TIFF)

S2 Fig. Egger’s test result for diabetes mellitus and its association with central obesity, and overweight/obesity among adults.

(TIFF)

Acknowledgments

We would like to thank Dilla University for supporting this systematic review and meta-analysis.

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.World Health Organization. Diabetes Fact Sheet World Health Organization, 2013; No312. http://www.who.int/en/news-room/fact-sheets/detail/diabetes.
  • 2.Tabish SA. Is diabetes becoming the biggest epidemic of the twenty-first century? Int J Health Sci.2007;1(2):5–5. [PMC free article] [PubMed] [Google Scholar]
  • 3.Prevalence Cheng D., predisposition and prevention of type II diabetes. Nutrition Metab.2005; 2:29. doi: 10.1186/1743-7075-2-29 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019. Nov; 157:107843. doi: 10.1016/j.diabres.2019.107843 Epub 2019 Sep 10. . [DOI] [PubMed] [Google Scholar]
  • 5.IDF, author. IDF Diabetes Atlas. 6th ed. Brussels: International Diabetes Federation, Belgium; 2013. [Google Scholar]
  • 6.The prevalence of diabetes in the African region September 11,2019 https://www.openaccessgovernment.org/diabetes-african-region/73153/ accessed July 23 2021.
  • 7.Zekewos A, Loha E, Egeno T, Wubshet K, Merga Z. Prevalence of Diabetes Mellitus and Associated Factors in Southern Ethiopia: A Community Based Study. Ethiop J Health Sci. 2018;28(4):451–60. doi: 10.4314/ejhs.v28i4.11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z (Editors). JBI Manual for Evidence Synthesis. JBI, 2020. https://synthesismanual.jbi.global. [Google Scholar]
  • 10.Wolde Haileab Fekadu, Derso Terefe, Biks Gashaw Andargie, Yitayal Mezgebu, Ayele Tadesse Awoke, Gelaye Kassahun Alemu, et al. High Hidden Burden of Diabetes Mellitus among Adults Aged 18 Years and Above in Urban Northwest Ethiopia. Journal of Diabetes Research. 2020. doi: 10.1155/2020/9240398 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Addisu Tadesse Sahile Bekele GE. Prevalence of Diabetes Mellitus and Associated Factors in Addis Ababa Public Health Facilities, Addis Ababa, Ethiopia, 2016. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Endris Toyba, Worede Abebaw, Asmelash D. Prevalence of Diabetes Mellitus, Prediabetes and Its Associated Factors in Dessie Town, Northeast Ethiopia: A Community-Based Study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2019. doi: 10.2147/DMSO.S225854 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Woldesemayat Belete, Amare Hiwot, Ataro Zerihun, Gutema Gadissa, Kidane Eleni, Belay Desalegn, et al. Prevalence of Diabetes Mellitus and Associated Risk Factors Among Adults Attending at Feres Meda Health Centre, Addis Ababa, Ethiopia. International Journal of Biomedical Materials Research. 2019. [Google Scholar]
  • 14.Kassa Andargachew, Woldesemayat EM. Hypertension and Diabetes Mellitus among Patients at Hawassa University Comprehensive Specialized Hospital, Hawassa, Southern Ethiopia. International Journal of Chronic Diseases. 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Shiferaw Birhanu Aynalem, Zeleke aAJ. Prevalence of Diabetes Mellitus and Its Risk Factors among Individuals Aged 15 Years and Above in Mizan-Aman Town, Southwest Ethiopia, 2016: A Cross Sectional Study. 2018. [DOI] [PMC free article] [PubMed]
  • 16.Animaw W, Seyoum Y. Increasing prevalence of diabetes mellitus in a developing country and its related factors. PloS one. 2017;12(11):e0187670. doi: 10.1371/journal.pone.0187670 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wondemagegn Amsalu Taye, Bizuayehu Habtamu Mellie, Abie Dagninet Derebe, Ayalneh Getachew Mengistu, Tiruye Tenaw Yimer, Tessema MT. Undiagnosed diabetes mellitus and related factors in East Gojjam (NW Ethiopia) in 2016: a community-based study. Journal of Public Health Research. 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Abebaw Worede, Shitaye Alemu, Yalemzewod Assefa Gelaw, Abebe M. The prevalence of impaired fasting glucose and undiagnosed diabetes mellitus and associated risk factors among adults living in a rural Koladiba town, northwest Ethiopia. 10.1186/s13104-017-2571-3. BMC Research Notes. 2017. [DOI] [PMC free article] [PubMed]
  • 19.Tesfaye T, Shikur B, Shimels T, Firdu N. Prevalence and factors associated with diabetes mellitus and impaired fasting glucose level among members of federal police commission residing in Addis Ababa, Ethiopia. BMC endocrine disorders. 2016;16(1):68-. doi: 10.1186/s12902-016-0150-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Solomon Mekonnen Abebe Yemane Berhane, Worku Alemayehu, Assefa A. Diabetes mellitus in North West Ethiopia: a community based study. BMC Public Health. 2014. doi: 10.1186/1471-2458-14-97 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Uhomoibhi PE. Prevalence And Determinants Of Diabetes Mellitus And Impaired Fasting Glucose Among Workers At The Spare Parts Share Company, Akaki, Ethiopia. 2003.
  • 22.Dereje N., Earsido A., Temam L. and Abebe A., 2020. Prevalence and Associated Factors of Diabetes Mellitus in Hosanna Town, Southern Ethiopia. Annals of Global Health, 86(1), p.18. doi: 10.5334/aogh.2663 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Seifu Yohannes, Tsegaw Desalegn, Haji Yusuf, Ejeso A. Prevalence and Associated Factors of Diabetes Mellitus Among Adult Population in Hawassa Zuria Woreda, Sidama Region, Ethiopia. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020. doi: 10.2147/DMSO.S275230 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Asamoah-Boaheng M., Sarfo-Kantanka O., Tuffour A. B., Eghan B. & Mbanya J. C. Prevalence and risk factors for diabetes mellitus among adults in Ghana: A systematic review and meta-analysis. Int. Health 11(2), 83–92 (2019). doi: 10.1093/inthealth/ihy067 [DOI] [PubMed] [Google Scholar]
  • 25.Müller-Wieland D. et al. Survey to estimate the prevalence of type 2 diabetes mellitus in hospital patients in Germany by systematic HbA1c measurement upon admission. Int. J. Clin. Pract. 72(12), e13273 (2018). doi: 10.1111/ijcp.13273 [DOI] [PubMed] [Google Scholar]
  • 26.Apidechkul T. Prevalence and factors associated with type 2 diabetes mellitus and hypertension among the hill tribe elderly populations in northern Thailand. BMC Public Health 18(1), 1–17 (2018). doi: 10.1186/s12889-018-5607-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Birabaharan M., Strunk A., Garg A. & Hagmann S. 340. Prevalence of type ii diabetes mellitus among patients living with HIV in the United States. In Paper Presented at: Open Forum Infectious Diseases (2019). doi: 10.1093/ofid/ofz360.413 30976605 [DOI] [Google Scholar]
  • 28.Dedov I. et al. Prevalence of type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study). Diabetes Res. Clin. Pract. 115, 90–95 (2016). doi: 10.1016/j.diabres.2016.02.010 [DOI] [PubMed] [Google Scholar]
  • 29.Cicero AFG, Fogacci F, Tocci G, Ventura F, Presta V, Grandi E, et al. Awareness of major cardiovascular risk factors and its relationship with markers of vascular aging: Data from the Brisighella Heart Study. Nutr Metab Cardiovasc Dis. 2020. Jun 9;30(6):907–914. doi: 10.1016/j.numecd.2020.03.005. Epub 2020 Mar 16. . [DOI] [PubMed] [Google Scholar]
  • 30.Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980e2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388(10053):1459e544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Xuan Chen, Mingrui Duan, Rui Hou, Manqi Zheng, Haibin Li, Manjot Singh, et al. Prevalence of Abdominal Obesity in Chinese MiddleAged and Older Adults with a Normal Body Mass Index and Its Association with Type 2 Diabetes Mellitus: A Nationally Representative Cohort Study from 2011 to 2018. 2021. [DOI] [PMC free article] [PubMed]

Decision Letter 0

Paolo Magni

13 May 2022

PONE-D-22-05097Diabetes Mellitus and its Association with Central Obesity, Overweight/Obesity among adults in Ethiopia. A Systematic Review and Meta-AnalysisPLOS ONE

Dear Dr. Muche,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Plesse address all reviewer's comments.

Please submit your revised manuscript by Jun 27 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Paolo Magni

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please upload a new copy of Figure 5 as the detail is not clear. Please follow the link for more information: " ext-link-type="uri" xlink:type="simple">https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/" https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. Thank you for stating the following financial disclosure:

“NO: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript”

At this time, please address the following queries:

a)        Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b)        State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c)        If any authors received a salary from any of your funders, please state which authors and which funders.

d)        If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

please see reviewer's comments

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Editor,

I carefully read the manuscript by Muche et al.

My comments and suggestions are the following:

- Line 125: The authors referred to an obsolete version of PRISMA guidelines (Ref. 8). They should revise the analysis following the updated PRISMA guidelines (that have been published early last year).

- Line 152: The authors should also perform Begg test.

- Line 152-153: The authors should specify how sensitivity analysis was performed.

- Table 1: Information regarding the prevalence by sex should be included in the table.

- The authors should consider to refer to doi: 10.1016/j.numecd.2020.03.005 in their manuscript.

- The limitations of the analysis should be more deeply discussed.

- English language needs to be revised.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Jun 10;17(6):e0269877. doi: 10.1371/journal.pone.0269877.r002

Author response to Decision Letter 0


24 May 2022

Reviewer #1

Reviewers comment

1 Line 125: The authors referred to an obsolete version of PRISMA guidelines (Ref. 8). They should revise the analysis following the updated PRISMA guidelines (that have been published early last year). Thank you very much for your suggestion. It has been corrected based on the recent PRISMA-2020 guidelines” page 13

2 Line 152: The authors should also perform Begg test. Thank you very much for your insightful comments. As per the reviewer’s comment it has been corrected. Page 9

3 Line 152-153: The authors should specify how sensitivity analysis was performed. Thanks! The authors addressed the given comments. Page 7

4 Table 1: Information regarding the prevalence by sex should be included in the table. Thanks for your insightful comments. It would have been better if we could have this variable, but most of the eligible studies lack this variable. So, we are unable to assess the prevalence based on sex.

5 The authors should consider to refer to doi: 10.1016/j.numecd.2020.03.005 in their manuscript. Thanks for the comments. We found this literature crucial for our review. Page 11 and reference number 30.

6 The limitations of the analysis should be more deeply discussed. As per the comment it has be discussed Page 12

7 English language needs to be revised. Thanks!. We authors made a correction as per the given comment. Throughout the document

Attachment

Submitted filename: Response_To_Reviewers.docx

Decision Letter 1

Paolo Magni

30 May 2022

Diabetes mellitus and its association with central obesity, and overweight/obesity among adults in Ethiopia. A systematic review and meta-analysis

PONE-D-22-05097R1

Dear Dr. Temesgen Muche,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Paolo Magni

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

The paper has been significantly improved.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I carefully read the revised version of the manuscript that is significantly improved in comparison with the previous version.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Paolo Magni

2 Jun 2022

PONE-D-22-05097R1

Diabetes mellitus and its association with central obesity, and overweight/obesity among adults in Ethiopia. A systematic review and meta-analysis

Dear Dr. Muche:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Paolo Magni

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. PRISMA 2020 checklist.

    (DOCX)

    S2 Table. Literature screening Microsoft excel sheet.

    (DOCX)

    S3 Table. JBI-quality assessment tool for cross-sectional studies.

    (DOCX)

    S1 Fig. Begg’s test analysis for diabetes mellitus and its association with central obesity, and overweight/obesity among adults.

    (TIFF)

    S2 Fig. Egger’s test result for diabetes mellitus and its association with central obesity, and overweight/obesity among adults.

    (TIFF)

    Attachment

    Submitted filename: Response_To_Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES